Abstract Views :532 |
PDF Views:0
Authors
Affiliations
1 Associate Professor, Department of Management Studies, Karunya Institute of
Technology and Sciences, Coimbatore, IN
2 Professor & Head, Department of Management Studies & Commerce, Karunya Institute of
Technology and Sciences, Coimbatore, IN
3 Formerly Student of MBA (Finance), Department of Management Studies, Karunya Institute of Technology and Sciences, Coimbatore, IN
Source
Indian Journal of Public Health Research & Development, Vol 11, No 2 (2020), Pagination: 719-725
Abstract
The purpose of this paper is to identify the cost variables that are relatively important in discriminating Pharmaceutical Companies. The manufacturing costs are a major part of company’s total expenses in pharmaceutical industry(1). In this study, a thorough investigation on the cost components and income categories of pharmaceutical companies are analyzed and their relationships were found to understand,to know the difference among various types of pharmaceutical companies. The analysis on the data set between 2009 and 2018 reveals that, costs play a dominant role and they are different for all the five companies that are listed. The study also reveals that there is a considerable amount of discrimination in the cost of manufacturing and operating expenses which discriminate the pharmaceutical companies in their approach towards the market. The Structural Equation Modelling has explained that the variables chosen has a good impact as predicted and it implies that the performance of the company is growing among the years chosen for the study.
Keywords
COGS, Pharmaceutical Manufacturing Companies, Discriminate, Structural Equation Modeling.
